Literature DB >> 10786951

Microbial resistance: lessons from the EPIC study. European Prevalence of Infection.

J L Vincent1.   

Abstract

In 1992, a one day point prevalence study (EPIC) was conducted in European intensive care units (ICUs) to determine the prevalence of nosocomial infection among ICU patients. Of the 10,038 patients included, 45% were infected and 21% had a nosocomial ICU-acquired infection. Many of the organisms responsible for these infections were resistant to commonly used antibiotics. For example, 60% of the Staphylococcus aureus isolated were resistant to methicillin and 46% of Pseudomonas aeruginosa were resistant to gentamicin. The incidence of nosocomial infection varied between countries as did the incidence of antibiotic resistance. Mortality rates were higher in countries with higher rates of nosocomial infection and higher again in those countries with higher rates of resistant organisms. Antibiotic resistance is rising and clearly efforts to contain its development and spread are vital. Basic infection control procedures such as hand-washing must be developed and implemented, and antibiotic prescribing needs to be rationalized. The international variations in resistance rates, even within Europe, highlight the importance of being familiar with local resistance patterns when prescribing. The assistance of an infectious diseases specialist can be invaluable in providing a global overview of the local microbial milieu and of antibiotic resistance patterns. Epidemiological studies of this sort can provide useful information which can be used to stimulate debate on the reasons behind regional differences in infection and help in the development of strategies to combat the rising tide of microbial antibiotic resistance.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10786951     DOI: 10.1007/s001340051111

Source DB:  PubMed          Journal:  Intensive Care Med        ISSN: 0342-4642            Impact factor:   17.440


  19 in total

1.  Surveillance of microbial resistance in European Intensive Care Units: a first report from the Care-ICU programme for improved infection control.

Authors:  Håkan Hanberger; Dilek Arman; Hans Gill; Vlastimil Jindrák; Smilja Kalenic; Andrea Kurcz; Monica Licker; Paul Naaber; Elizabeth A Scicluna; Václav Vanis; Sten M Walther
Journal:  Intensive Care Med       Date:  2008-08-01       Impact factor: 17.440

2.  Sporadic isolations of a multi-drug resistant Pseudomonas aeruginosa clone during a 14-month epidemic in a general hospital in Hiroshima.

Authors:  S Kouda; Y Fujiue; Y Watanabe; M Ohara; S Kayama; F Kato; J Hisatsune; K Tsuruda; A Matsubara; M Doi; M Kuwabara; M Sugai
Journal:  Infection       Date:  2011-04-22       Impact factor: 3.553

3.  Challenges of biofilm control and utilization: lessons from mathematical modelling.

Authors:  Paulina A Dzianach; Gary A Dykes; Norval J C Strachan; Ken J Forbes; Francisco J Pérez-Reche
Journal:  J R Soc Interface       Date:  2019-06-12       Impact factor: 4.118

4.  Successful long-term program for controlling methicillin-resistant Staphylococcus aureus in intensive care units.

Authors:  Jean-Christophe Lucet; Xavier Paoletti; Isabelle Lolom; Catherine Paugam-Burtz; Jean-Louis Trouillet; Jean-François Timsit; Claude Deblangy; Antoine Andremont; Bernard Regnier
Journal:  Intensive Care Med       Date:  2005-07-01       Impact factor: 17.440

5.  Antimicrobial use and microbiological testing in district general hospital ICUs of the Veneto region of north-east Italy.

Authors:  P Benedetti; A M Sefton; M Menegozzo; C Guerriero; G Bordignon; G Da Rin; C Romualdi; G Pellizzer; D M Livermore
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-06-15       Impact factor: 3.267

6.  Molecular characterization of an epidemic clone of panantibiotic-resistant Pseudomonas aeruginosa.

Authors:  A Deplano; O Denis; L Poirel; D Hocquet; C Nonhoff; B Byl; P Nordmann; J L Vincent; M J Struelens
Journal:  J Clin Microbiol       Date:  2005-03       Impact factor: 5.948

7.  Virulence, Speciation and Antibiotic Susceptibility of Ocular Coagualase Negative Staphylococci (CoNS).

Authors:  Ravindran Priya; Arumugam Mythili; Yendremban Randhir Babu Singh; Haridas Sreekumar; Palanisamy Manikandan; Kanesan Panneerselvam; Coimbatore Subramanian Shobana
Journal:  J Clin Diagn Res       Date:  2014-05-15

8.  Clinical outcomes of Pseudomonas aeruginosa pneumonia in intensive care unit patients.

Authors:  Mario Tumbarello; Gennaro De Pascale; Enrico Maria Trecarichi; Teresa Spanu; Federica Antonicelli; Riccardo Maviglia; Mariano Alberto Pennisi; Giuseppe Bello; Massimo Antonelli
Journal:  Intensive Care Med       Date:  2013-02-01       Impact factor: 17.440

9.  Effect of hospitalization and antimicrobial therapy on antimicrobial resistance of colonizing Staphylococcus epidermidis.

Authors:  Ariane Knauer; Petra Fladerer; Christina Strempfl; Robert Krause; Christoph Wenisch
Journal:  Wien Klin Wochenschr       Date:  2004-07-31       Impact factor: 1.704

10.  Generalized additive model demonstrates fluoroquinolone use/resistance relationships for Staphylococcus aureus.

Authors:  Pierre Berger; Laurence Pascal; Catherine Sartor; Jean Delorme; Philippe Monge; Christine Penot Ragon; Martine Charbit; Roland Sambuc; Michel Drancourt
Journal:  Eur J Epidemiol       Date:  2004       Impact factor: 8.082

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.